open access
Interstitial lung disease associated with docetaxel in a patient treated for breast cancer — a case report
open access
Abstract
Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.
Abstract
Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.
Keywords
interstitial lung disease, breast cancer, docetaxel
About this articleTitle
Interstitial lung disease associated with docetaxel in a patient treated for breast cancer — a case report
Journal
Advances in Respiratory Medicine
Issue
Article type
Case report
Pages
378-382
DOI
10.5603/PiAP.2015.0060
Pubmed
Bibliographic record
Pneumonol Alergol Pol 2015;83(5):378-382.
Keywords
interstitial lung disease
breast cancer
docetaxel
Authors
Monika Pankowska-Supryn
Monika Załęska
Barbara Roszkowska-Śliż
Kazimierz Roszkowski-Śliż